NCT00248144View on ClinicalTrials.gov

A Study to Evaluate the Safety and Efficacy of Single Day or Single Dose Famciclovir for the Treatment of Recurrent Herpes Labialis

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2003

Study Completion Date

July 31, 2007

Conditions
Recurrent Herpes Labialis
Interventions
DRUG

Famciclovir

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00248144 - A Study to Evaluate the Safety and Efficacy of Single Day or Single Dose Famciclovir for the Treatment of Recurrent Herpes Labialis | Biotech Hunter | Biotech Hunter